Worldwide Dyslipidemia Guidelines
- PDF / 1,073,285 Bytes
- 7 Pages / 595.276 x 790.866 pts Page_size
- 30 Downloads / 218 Views
LIPIDS (E. MICHOS, SECTION EDITOR)
Worldwide Dyslipidemia Guidelines Marcin Adam Bartlomiejczyk 1 & Peter Penson 2 & Maciej Banach 1,3
# The Author(s) 2019
Abstract Purpose of Review This review aims to identify common features of guidelines by comparing and summarizing similarities between five guidelines distributed by high-profile cardiovascular societies across the globe. We include guidelines from North America: ACC/AHA (2013 American College of Cardiology/American Heart Association Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults) and CCS (2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult) and from Europe: PoLA (2016 Polish Lipid Association), ESC/EAS (2016 European Society for Cardiology/European Atherosclerosis Society Guidelines for the Management of Dyslipidemias), and NICE (National Institute for Health and Care Excellence) from the UK. We also include the 2016 Chinese guidelines for the management of dyslipidemia in adults in this comparison. Recent Findings All of these guidelines employ a rigorous review of clinical evidence and emphasize the immense importance of statins in the primary and secondary prevention of atherosclerotic cardiovascular disease. Moreover, they place great emphasis on the dialog between the clinician and the patient regarding treatment and the risks associated with it. Summary Despite the differences in statin intensities, safety concerns, use of risk estimators, or treatment of specific patient subgroups, there are more similarities than differences between the guidelines from both a clinical and practical point of view. Physicians ought to understand both similarities and differences in guideline recommendations to make the right decision regarding statin therapy for individual patients. Keywords Dyslipidemia . Statin treatment . Clinical practice guidelines . Risk factors . Cardiovascular risk
Introduction The standard definition of clinical practice guidelines (CPGs) is “systematically developed statements to assist practitioners and patient decisions about appropriate health care for specific circumstances” [1]. CPGs are based on evidence, literature data, and medical principles [2]. Understanding the limitations of accessible evidence and This article is part of the Topical Collection on Lipids * Marcin Adam Bartlomiejczyk [email protected] 1
Department of Hypertension, Chair of Nephrology and Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, Zeromskiego 113, 90-549 Lodz, Poland
2
School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK
3
Polish Mother’s Memorial Hospital Research Institute, Lodz, Poland
an awareness of other available guidelines will support specialists to make personalized decisions with patients and improve the clinician–patient discussion [3, 4]. We need to create universal solutions for CPG on dyslipidemia to have guide
Data Loading...
